Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata

Basit Öğe Kaydı
dc.contributor.authorBilgic, O.
dc.contributor.authorBilgic, A.
dc.contributor.authorBahali, K.
dc.contributor.authorBahali, A. G.
dc.contributor.authorGurkan, A.
dc.contributor.authorYilmaz, S.
dc.date.accessioned2020-03-26T18:58:27Z
dc.date.available2020-03-26T18:58:27Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractBackgroundThere is a very limited amount of data available regarding the relationship between alopecia areata (AA) and psychiatric morbidity and quality of life (QoL) in children and adolescents. ObjectivesThe aim of this study was to determine the psychiatric state and health-related quality of life (HRQL) of children and adolescents with AA, as well as their relationships with clinical parameters. MethodsThe sample consisted of 74 children with AA aged 8-18years. Questionnaires were used to evaluate the psychiatric status and HRQL of the patients. The study and control groups were divided into child and adolescent groups to exclude the effect of puberty on psychological condition. ResultsIn the child group, patients had higher state anxiety and trait anxiety scores; they also had lower parent-rated psychosocial and total area HRQL scores than the controls did. In addition, the depression score was prone to show a positive relationship with having AA in the children. In the adolescent group, however, only the state anxiety score had a significant association with AA. All of the parent-rated HRQL scores were also prone to being lower compared with controls in this age group. Regarding determinants of HRQL, prolonged disease duration and later disease onset had positive effects, whereas severity of scalp involvement, trait anxiety and depression had negative effects, for the sample as a whole. ConclusionsAlopecia areata is associated with poor psychiatric status and QoL, especially in childhood. The impact of the disease on QoL occurs through both clinical and psychiatric parameters.en_US
dc.identifier.doi10.1111/jdv.12315en_US
dc.identifier.endpage1468en_US
dc.identifier.issn0926-9959en_US
dc.identifier.issn1468-3083en_US
dc.identifier.issue11en_US
dc.identifier.pmid24237476en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1463en_US
dc.identifier.urihttps://dx.doi.org/10.1111/jdv.12315
dc.identifier.urihttps://hdl.handle.net/20.500.12395/31099
dc.identifier.volume28en_US
dc.identifier.wosWOS:000344380600009en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWILEYen_US
dc.relation.ispartofJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titlePsychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areataen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu